+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differentiation of chronic lymphocytic leukemia from Hodgkin's disease using immunologic marker studies



Differentiation of chronic lymphocytic leukemia from Hodgkin's disease using immunologic marker studies



American Journal of Surgical Pathology 5(7): 707-710



Four consecutive lymph node biopsies from one patient showed features typical of lymphocyte-pre-dominant Hodgkin's disease. When the patient developed lymphocytosis of the peripheral blood and a staging bone marrow biopsy was found to have nodular lymphoid infiltrates atypical for Hodgkin's disease, the fourth node biopsy was performed in order to perform immunologic marker studies. A monoclonal cell population was identified and the lymph nodes were interpreted as chronic lymphocytic leukemia mimicking lymphocyte-predominant Hodgkin's disease. The diagnostic usefulness of immunologic marker studies stressed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 005159202

Download citation: RISBibTeXText

PMID: 7039376

DOI: 10.1097/00000478-198110000-00014


Related references

T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies. Veroffentlichungen aus der Pathologie 1975(0): 1-99, 1975

Alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders. American Journal of Pathology 97(1): 17-41, 1979

Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma. Acta Haematologica Polonica 23(1): 29-41, 1992

Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with epstein barr virus or phorbol ester 1. immunologic and morphologic studies. American Journal of Hematology 17(4): 335-348, 1984

Immunologic diagnosis of chronic lymphocytic leukemia and leukemic non hodgkin lymphomas with monoclonal antibodies bl ig l 1 bl dr 1 and bl t 2. Archiv fuer Geschwulstforschung 54(4): 325-332, 1984

Acute non-lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: cytogenetic studies. Cancer 44(5): 1592-1600, 1979

Acute lymphocytic leukemia in childhood: immunologic marker, cytogenetic, and molecular studies. Southern Medical Journal 80(7): 841-847, 1987

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Reed-Sternberg???Like Cells and Possible Transformation to Hodgkin??s Disease. The American Journal of Surgical Pathology 16(9): 859-867, 1992

Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunocytochemistry. Blood 94(7): 2537, 1999

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 94(5): 647-653, 2009

Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. American Journal of Surgical Pathology 16(9): 859-867, 1992

Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial. American Journal of Clinical Oncology 10(3): 194-195, 1987

Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma. Oncologist 24(9): 1219-1228, 2019

Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia. International Journal of Hematology 73(2): 230-235, 2001

Autologous lymphocytotoxins in differential immunodiagnosis of chronic lymphocytic leukemia and malignant non-Hodgkin's disease at the stage of leukemia development. Gematologiya i Transfuziologiya 37(7-8): 29-31, 1992